$0.8500
-0.09-9.84%
At close: -
$0.8499
-0.000100-0.01%
After Hours: Dec 20, 7:58 PM EDT
Comments
Loading...
Processa Pharma (NASDAQ:PCSA) Stock, Earnings Estimates, EPS, And Revenue
Processa Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Oct 30
EPS
$-1.030
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Processa Pharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
Processa Pharma (PCSA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-10-30 | $-1.03 | $-1.00 | -3.00 % |
| Jun 2024 | 2024-08-13 | $-1.01 | $-0.98 | -3.06 % |
| Dec 2023 | 2024-03-29 | $-1.68 | $-1.60 | -5.00 % |
| Mar 2023 | 2023-05-15 | $-3.60 | $-5.60 | 35.7 % |
Processa Pharma (PCSA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Processa Pharma (NASDAQ:PCSA) reporting earnings?
Processa Pharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on October 30, 2024 for Q3.
What were the latest earnings per share (EPS) for Processa Pharma (NASDAQ:PCSA)?
Processa Pharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on October 30, 2024 for Q3 and the Actual EPS was $-1.03, which missed the estimate of $-1.00.
What were Processa Pharma’s (NASDAQ:PCSA) revenues?
Processa Pharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on October 30, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.